BioSpace News Archive

Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived products and affiliated cell-based services in the following categories:

The Mesothelioma Compensation Center is incredibly passionate about making certain that a person who was exposed to asbestos at any type of nuclear power plant and now has mesothelioma or asbestos exposure lung cancer receives the very best possible financial compensation.

Pelitas (formerly DCS Global), the leader in Revenue Cycle Patient Access technology solutions, today announced that Tee Green, Chairman and CEO of 121G, LLC, has joined the Board of Director

IDbyDNA, a metagenomics technology company setting a new standard for the identification and understanding of microorganisms and their role in human health, today announced the appointment of two new members to its Scientific Advisory Board (SAB).

Eclipse Corporation and MC Integration announced today they have signed an agreement for an OEM partnership

Geyser Brands Inc (TSXV:GYSR) (the “Company”) announces GetFresh Ventures as its strategic partner for both the Company and its subsidiaries effective immediately

SKYN®, the premium condom and lubricant brand and first-ever polyisoprene, non-latex condom by LifeStyles, today announces its newest sexual wellness offering in the United States, SKYN® arise™ -- an erectile dysfunction (ED) medication that is conveniently prescribed through a secure online telemedicine service and delivered discreetly to your door.

The summit will be co-chaired by Kartik Konduri, M.D., co-medical director of the lung cancer center of excellence at Baylor Charles A. Sammons Cancer Center at Baylor University Medical Center, and David P. Mason, M.D., chief of thoracic surgery and lung transplantation for Baylor Scott & White Health.

Children’s Health Defense looks forward to the opportunity to have a neutral arbitrator scrutinize the legitimacy of the City’s order.

AbleTo, Inc., a leading provider of virtual behavioral health care proven to improve clinical outcomes and lower overall health care costs, announced today the appointment of Mary Ann Tocio to its Board of Directors.